Alexandria Real Estate Equities
ARE
#2283
Rank
NZ$13.82 B
Marketcap
NZ$79.98
Share price
2.61%
Change (1 day)
-53.52%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -NZ$29.98 Million

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are NZ$2.97 Billion. In 2024 the company made an earning of NZ$1.19 Billion, an increase over its 2023 earnings that were of NZ$0.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$29.98 Million-102.5%
2024 NZ$1.19 B96.11%
2023 NZ$0.61 B-53.56%
2022 NZ$1.31 B-3.96%
2021 NZ$1.37 B-20.26%
2020 NZ$1.71 B72.88%
2019 NZ$0.99 B3.11%
2018 NZ$0.96 B73.54%
2017 NZ$0.55 B464.88%
2016 NZ$98.37 M-77.32%
2015 NZ$0.43 B36.31%
2014 NZ$0.31 B-10.81%
2013 NZ$0.35 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$20.39 B-57,124.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$17.01 B-47,665.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.73 B-108,373.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$1.71 B-4,887.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.82 B-38,749.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.18 B-39,765.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$0.22 B-727.01%๐Ÿ‡บ๐Ÿ‡ธ USA